The features that should prompt assessment are: Severe, sudden pain in the upper right or upper central abdomen Pain radiating to the right shoulder or to the centre of the back Pain that comes in episodes lasting 30 minutes to several hours, particularly after meals Persistent nausea or vomiting beyond the expected GLP-1 side-effect window Fever, chills, or feeling systemically unwell Yellowing of the skin or eyes (jaundice) Dark urine or pale stools The last three suggest more serious complications and warrant urgent medical review
[4] [5] By activating GLP-1 receptors, retatrutide is thought to enhance insulin secretion in a glucose-dependent manner, suppress glucagon release, and reduce appetite by acting on satiety centres in the brain
By activating GLP-1 receptors in the brain, it promotes a sense of satiety, further reducing appetite
IGF-1 DES is the weapon of choice for targeting specific muscles, making it ideal for bodybuilders fine-tuning their physiques
10.1093/tropej/fmaa003 J Trop Pediatr
F.et al (1999)
